Expert Analyses of the following article:
Datacsope stock soars on takeover tlaks
Source: www.northjersey.com
June 9, 2008
Could be a smart move or could backfire
Author: GLG Expert Contributor
Author: GLG Expert Contributor
-Datascope has decided to exit the monitor market by selling a chunk of itself off, possibly making itself into a takeover candidate. The remaining units make stents, balloon catheters and other cardiac equipment. -One other effect is that it has placed itself into direct (rather than indirect) competition with deep-pocketed industry leaders like Boston Scientific.
June 5, 2008Datascope Benefits from Sale of Patient Monitoring Business
Author: Ken Powell, President, Genesis Business Development
The sale of Datascope's (NASDAQ: DSCP) patient monitoring business earlier this year to Mindray Medical (NYSE: MR) has resulted in several acquisition offers from unnamed companies. On Wednesday, Datascope's stock increased 11% in response to this news.
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

